Gene analysis (partner and localizer of brca2) targeted sequence analysis
Medicare pricing data for 52 providers across 9 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (partner and localizer of brca2) targeted sequence analysis (HCPCS code 81309) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $269.32, but hospitals typically charge $300.30 — a 1.1x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $269.32, your out-of-pocket cost would be approximately $53.86. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.1x more than what Medicare allows for this procedure. Medicare actually pays $269.32 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Illinois | $269 | $2,651 | 2 | 22 | +0.0% |
| Louisiana | $269 | $299 | 2 | 43 | +0.0% |
| New Jersey | $269 | $333 | 4 | 3,014 | +0.0% |
| Oklahoma | $269 | $346 | 3 | 303 | +0.0% |
| Pennsylvania | $269 | $275 | 2 | 2,125 | +0.0% |
| Texas | $269 | $281 | 15 | 9,344 | +0.0% |
| Arizona | $269 | $300 | 1 | 79 | +0.0% |
| Colorado | $269 | $1,191 | 1 | 13 | +0.0% |
| Florida | $269 | $343 | 13 | 1,110 | -0.1% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber